ATLAS / Macro Radar / Reporting / COYA

Coya Therapeutics, Inc. (COYA) reporting calendar

Coya Therapeutics, Inc. files periodic reports with the SEC as COYA on Nasdaq. Atlas tracks 14 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
23 Jul 2026 – 1 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
14

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open COYA market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001193125-26-218201
10-K31 Dec 202516 Mar 202675 days0001193125-26-107281
10-Q30 Sep 202512 Nov 202543 days0001193125-25-276058
10-Q30 Jun 202512 Aug 202543 days0000950170-25-106934
10-Q31 Mar 202513 May 202543 days0000950170-25-069824
10-K31 Dec 202418 Mar 202577 days0000950170-25-040782
10-Q30 Sep 20246 Nov 202437 days0000950170-24-121837
10-Q30 Jun 202412 Aug 202443 days0000950170-24-095075
10-Q31 Mar 20249 May 202439 days0000950170-24-057056
10-K31 Dec 202319 Mar 202479 days0000950170-24-033161
10-Q30 Sep 20238 Nov 202339 days0000950170-23-060718
10-Q30 Jun 20238 Aug 202339 days0000950170-23-039354
10-Q31 Mar 202310 May 202340 days0000950170-23-020076
10-K31 Dec 202229 Mar 202388 days0000950170-23-010599

Source: SEC EDGAR company submissions for CIK 0001835022. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.